Published 2 years ago

FDA Expands Use Of Remdesivir For Some Non-Hospitalized Covid Patients

Summary by Ground News

Antiviral drug remdesivir can be administered outside of a hospital for some mild-to-moderate covid patients. The intravenous drug that is infused over three days would have to be delivered at an outpatient clinic. Utah is eliminating race and sex as factors in allocating its limited supply of monoclonal antibodies and antiviral treatments.

0 Articles

All

Left

Center

Right

Medscape

FDA Expands Use of Remdesivir

The US health regulator has expanded its approval for remdesivir. Reuters Health Information

2 years ago·United States

Read Full Article

Healio

FDA expands use of remdesivir in patients with COVID-19

The FDA recently announced it has expanded its approval of Gilead Sciences’ antiviral drug remdesivir — marketed in the U.S. as Veklury — to allow certain outpatients with COVID-19 to receive it. According to a press release, the FDA expanded the approval of IV remdesivir to include nonhospitalized adults and children aged 12 years and older weighing at least 40 kg (about 88

2 years ago

Read Full Article

Kaiser Health News

FDA Expands Use Of Remdesivir For Some Non-Hospitalized Covid Patients

The Food and Drug Administration authorized Gilead Sciences’ antiviral treatment remdesivir to be administered outside of a hospital for some mild-to-moderate covid patients. The intravenous …

2 years ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.